MS

Mathew Sunil

Active Director Director DIN 02731682
DIN 02731682 First appointment Jun 2009 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2009
Shareholding value β€’β€’β€’β€’ Premium profile

About Mathew Sunil

Data last updated:

Mathew Sunil is a Director at Chennat Pharmaceuticals Pvt Ltd (since 2009). The company operates in Pharma.

DIN 02731682
Primary Designation Director
Industry Pharma
First Appointment 15 Jun 2009
Oldest Company Age 33 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Chennat Pharmaceuticals Pvt Ltd U24231KL1993PTC007225
Director15 Jun 20091993Active

Directorship timeline

Open interactive timeline →
Chennat Pharmaceuticals Pvt Ltd
Premium access

Shareholding and investment profile for Mathew Sunil

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mathew Sunil

Mathew Sunil currently holds 1 directorship: Chennat Pharmaceuticals Pvt Ltd (Director, since 15 Jun 2009).

Mathew Sunil was first appointed on 15 Jun 2009 as Director at Chennat Pharmaceuticals Pvt Ltd.

The current boards of Mathew Sunil's companies include Chackalathu Kuriakose Mohanan (Chennat Pharmaceuticals Pvt Ltd), Mammen Pulithanathu Kochummen (Chennat Pharmaceuticals Pvt Ltd), Ramachandran Pillai (Chennat Pharmaceuticals Pvt Ltd), Shaji George (Chennat Pharmaceuticals Pvt Ltd), Thomas Karyadil Kuruvilla (Chennat Pharmaceuticals Pvt Ltd).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available